Hara Y, Moro K, Ichikawa H, Tsuchida J, Uchida H, Naruse K, et al. Clinical Utility of Targeted Next-Generation Sequencing for Determining Human Epidermal Growth Factor Receptor 2 Status and Optimizing Targeted Therapy in Breast Cancer. World J Oncol [Internet]. 2025 Jul. 8 [cited 2025 Jul. 12];. Available from: https://wjon.elmerpub.com/wjon/article/view/2583